Stryker Corporation (FRA:SYK)

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Instruments Revenue	2.97B	2.83B	Log In	Log In	Log In	Upgrade
Endoscopy Revenue	3.61B	3.39B	Log In	Log In	Log In	Upgrade
Medical Revenue	4.02B	3.85B	Log In	Log In	Log In	Upgrade
Neurovascular Revenue	1.57B	1.31B	Log In	Log In	Log In	Upgrade
Neuro Cranial Revenue	2.22B	2.14B	Log In	Log In	Log In	Upgrade
MedSurg & Neurotechnology Revenue	14.39B	13.52B	Log In	Log In	Log In	Upgrade
Knees Revenue	2.54B	2.45B	Log In	Log In	Log In	Upgrade
Hips Revenue	1.79B	1.70B	Log In	Log In	Log In	Upgrade
Trauma and Extremities Revenue	3.75B	3.51B	Log In	Log In	Log In	Upgrade
Spinal Implants Revenue	661.00M	707.00M	Log In	Log In	Log In	Upgrade
Other Orthopaedics Revenue	694.00M	712.00M	Log In	Log In	Log In	Upgrade
Orthopaedics Revenue	9.43B	9.08B	Log In	Log In	Log In	Upgrade
Revenue (Other)	-23.82B	-22.60B	Log In	Log In	Log In	Upgrade
Revenue (Total)	23.82B	22.60B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Revenue (Total)	23.82B	22.60B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
United States Revenue	17.98B	16.94B	Log In	Log In	Log In	Upgrade
International Revenue	5.84B	5.65B	Log In	Log In	Log In	Upgrade
Revenue (Total)	23.82B	22.60B	Log In	Log In	Log In	Upgrade

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
MedSurg & Neurotechnology Operating Income	4.38B	4.00B	Log In	Log In	Log In	Upgrade
Orthopaedics Operating Income	2.63B	2.59B	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-3.39B	-2.91B	Log In	Log In	Log In	Upgrade
Operating Income (Total)	3.62B	3.69B	Log In	Log In	Log In	Upgrade

EBIT 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Operating Income (Total)	3.62B	3.69B	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Organic Net Sales Growth	-	10.20%	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.